Dissertation > Excellent graduate degree dissertation topics show

Gene Therapy for Hemophilia A Using Human Ribosomal DNA-targeting Vector Containing hFⅧ

Author: LiuXiongZuo
Tutor: XiaJiaHui;LiangDeSheng;DaiHePing
School: Central South University
Course: Genetics
Keywords: ribosomal DNA locus site-specific integration reconstructive hFⅧ hemophilia A gene therapy
CLC: R554.1
Type: PhD thesis
Year: 2007
Downloads: 150
Quote: 2
Read: Download Dissertation


Hemophilia A is an X chromosome-linked recessive inheritablebleed-ing disorder with an estimated incidence of 1-2 per 10000 males.Patients wi-th Hemophilia A experience spontaneous bleeding into joints,soft tissues and other sites. Uncontrolled haemorrhagic episodes arecrippling and potentially lifethreatening. Hemophilia A is caused by adeficiency or abnormality in factorⅧ. which is one of the most attractivecandidates for gene therapy.The expression level of recombinant hFⅧis extremely low in mam-malian cells. The major factors that limit hFⅧexpression have been ide-ntified: (ⅰ) There is a 1.2kb stretch of FⅧcDNA within the FⅧcodingregion having a deleterious effect on RNA accumulation; (ⅱ) the primarytranslation product is inefficiently transported from the endoplasmic rect-iculum (ER) to the Golgi apparatus; and (ⅲ) FⅧis very sensitive to theprotease, and von Willebrand factor (vWF) are required for stable accu-mulation of FⅧ. Results of many laboratories showed that modifying thehFⅧmolecule is an efficient way to improve its expression in mamm-alian cells. The major modifications of hFⅧmolecule are as follow: 1,deletion of B domain; 2, deletion of 5’-UTR and 3’-UTR; 3, insertion ofintron of ApoA-1. Our lab had generated hFⅧ-BSP which contain themodification of hFⅧdescribed above. In this study, we modified the hFⅧ-BSP to hFⅧ-SK39 as follows: 1, Kozak box was inserted justbefore the initial code of hFⅧ-BSP, which can improve the translationefficiency of hFⅧ; 2, L303E & F309S, which can enhance the secretionof functional hFⅧ.In gene therapy, one of the most important issues is the choice ofvectors. Viral vectors are capable of efficiently delivering geneticmaterial into cells in vivo and in vitro, and about 70% of the clinical trialsare performed using viral vectors. However, their safety is of seriousconcern, pHrneo is a new type of nonviral vector previously developed byour group, which can target a foreign therapeutic gene into humanribosomal DNA (hrDNA) locus in HT1080 cells.In this study, firstly, we transfected HT1080 with pcDBSP(containing hFⅧ-BSP) and pcDSK39 (containing hFⅧ-SK39) usingelectroporation. The expression of hFⅧ-SK39 and hFⅧ-BSP in HT1080were tested. Secondly, we inserted expression cassette of hFⅧ-SK39 intopHrneo to construct targeting vector: pHrneo-SK39. Throughelectroporation of pHrneo-SK39 into HL7702 cells (human hepatocyte),we identified the homologous recombinants by PCR. The expression ofhFⅧ-SK39 and growth character of the site-specific integration cellswere tested. Finally, pHrneo-SK39 was injected into the tail vein ofBalb/c-nu mouse by high-pressure hydrodynamic injection. We tested theconcentration of hFⅧ-SK39 in Balb/c-nu mice, and examined the toxicity in the mouse li-vers after the injection of pHrneo-SK39.Our results show that①, the expression level of hFⅧ-BSP andhFⅧ-SK39 in HT1080 are 2.99±0.28 ng·10-6cells·24 h-1 and 9.90±1.89ng·10-6cells·24 h-1 respectively.②,The hFⅧ-SK39 was successfullytargeted into hrDNA locus of HL7702 by pHrneo-SK39, and theefficiency of site-specific int-egration was 1.1×10-5.③, The hFⅧ-SK39at the hrDNA locus of HL7702 was found to be able to express efficiently(4.3±0.9 ng·10-6cells·24 h-1), and the growth character ofsite-integration cells was normal.④, the expression of hFⅧ-SK39 insite-integration cells was stable.⑤, pHrneo-SK39 can express inBalb/c-nu mice, and the highest expression level is 4.56ng/ml in bloodplasm.In short, we think that pHrneo-SK39 may find uses in gene therapyfor hemophilia A.

Related Dissertations

  1. Polyethylenimine Conjugated Stearic Acid-g-chitosan Oligosaccharide Micelles for Antitumor Gene Therapy,R450
  2. Studies on Construction of Specific Gland Expressional Vector of HLF and Modified Fibroblast Cell Line,Q78
  3. The Construction and Evaluation of a Novel Non-viral Gene Transfection System and Its Application in Mesenchymal Stem Cells Gene Recombination,R346
  4. The Eukaryotic Expression Vector Construction of pIRES2-EGFP-hIL-12-HSP70 and Its Influence on the Growth of 7402 Liver Cancer Cell,R346
  5. Improvement of the Result of Autologous Fat Transplantation in Facial Recontouring Surgery by Using "Cocktail" Therapy,R622
  6. Clinical Analysis of Multifocal Papillary Thyroid Carcinoma,R736.1
  7. Experimental Studies on Therapy of Lung Cancer by VEGF-C siRNA Mediated by Liposomes,R734.2
  8. Experimental Study on Enhanced Anti-tumor Activity and Chemosensitivity of Co-expression by Ad-ING4-IL-24 Double-gene for Lung Cancer in Vitro,R734.2
  9. Screening and Analysis of Coagulation Factor Ⅷ Inhibitor and Development Related Factors in Hemophilia a Patients,R554.1
  10. The Therapeutic Effects of M4 to Ovarian Cancer Cell Lines and the Primary Mechanism,R737.31
  11. Research of Damage Efficiency by Livin/Survivin RNA Interference on Colorectal Cancer Cell Mediated by mPEGylated-chitosan Nanoparticles,R735.34
  12. Glucagon - like peptide-1 and its analogs gene therapy for diabetes research,R587.1
  13. Experimental Study of the Effects of Bone Marrow Mesenchymal Stem Cells Transfected with Sonic Hedgehg Gene for the Chronic Ischemic Heart Disease,R541.4
  14. Generatioin of Induced Pluripotent Stem Cells from Adult Human Dermal Fibroblasts,R329
  15. Mutant D314A of Escherichia Coli Cytosine Deaminase Enhances Its Antitumor Effect Significantly,R735.35
  16. Adenovirus Delivered Tissue Inhibitor of Metalloproteinases-3 Sensitizes HPV Positive Cervical Cancer Cells to Irradiation in Vitro and Vivo,R737.33
  17. Construction of Recombinant Adenovirus Adv-AFPsiRNA and Study of Inhibition Effect of Adv-AFPsiRNA on Ovarian Carcinoma,R737.31
  18. IL-15 Gene Therapy of Colon Cancer in Mice,R735.35
  19. The in Vivo Study on Radioiodine Uptake in Hepatoma Cells Mediated by Recombinant Adenovirus Encoding Human Sodium Iodide Symporter Gene,R735.7
  20. Hydrodynamics-based Transfection of Plasmid Encoding RANK-Fc Protects Against Hepatic Ischemia/Reperfusion Injury in Mice,R657.3
  21. The Gene Detection and Carriers Analysis of Three Haemophilia B Families,R440

CLC: > Medicine, health > Internal Medicine > Blood and lymphatic system diseases > Blood diseases > Hemorrhagic disease > Hemophilia
© 2012 www.DissertationTopic.Net  Mobile